Association of Anti–Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma
Pharmacology, Toxicology and Pharmaceutical Science
2
5%
Biochemistry, Genetics and Molecular Biology
2
5%
Neuroscience
2
5%
Nursing and Health Professions
1
2%
Other
3
7%
Unknown
20
49%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2020.
All research outputs
#9,309,658
of 32,402,993 outputs
Outputs from JAMA Dermatology
#2,709
of 4,232 outputs
Outputs of similar age
#147,849
of 444,797 outputs
Outputs of similar age from JAMA Dermatology
#56
of 65 outputs
Altmetric has tracked 32,402,993 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 4,232 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 37.7. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,797 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.